Urethral toxicity vs. cancer control-Lessons to be learned from high-dose rate brachytherapy combined with intensity-modulated radiation therapy in intermediate- and high-risk prostate cancer

Ghadjar, Pirus; Rentsch, Cyrill A; Isaak, Bernhard; Behrensmeier, Frank; Thalmann, George N; Aebersold, Daniel M (2011). Urethral toxicity vs. cancer control-Lessons to be learned from high-dose rate brachytherapy combined with intensity-modulated radiation therapy in intermediate- and high-risk prostate cancer. Brachytherapy, 10(4), pp. 286-94. New York, N.Y.: Elsevier

Full text not available from this repository. (Request a copy)

To describe biochemical relapse-free survival (BRFS) and late toxicity after combined high-dose rate brachytherapy (HDR-B) and intensity-modulated radiation therapy (IMRT) in intermediate- and high-risk prostate cancer patients.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Radiation Oncology
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Radiation Oncology > Medical Radiation Physics
04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Urology

UniBE Contributor:

Ghadjar, Pirus; Isaak, Bernhard; Behrensmeier, Frank; Thalmann, George and Aebersold, Daniel

ISSN:

1538-4721

Publisher:

Elsevier

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:09

Last Modified:

06 Dec 2013 13:20

PubMed ID:

21030318

URI:

https://boris.unibe.ch/id/eprint/1048 (FactScience: 201766)

Actions (login required)

Edit item Edit item
Provide Feedback